Clinical Pharmacology - LABS6050

Looking for a different module?

Module delivery information

Location Term Level1 Credits (ECTS)2 Current Convenor3 2024 to 2025
Year 6 15 (7.5) Blanka Hilton checkmark-circle


A synopsis of the curriculum
• Evaluation of drug effects in humans
• Unwanted drug effects and adverse drug reactions
• Infection and inflammation
• Nervous system
• Cardiorespiratory and renal systems
• Blood and neoplastic disease
• Gastrointestinal system
• Endocrine system and metabolic disorders


Contact hours

Blended distance learning:
Contact Hours: 100 hours
Private Study Time: 50 hours
Total Learning Time: 150 hours

Method of assessment

2000 word Essay – 40%
2 hour Examination – 60%
The pass mark for each individual assessment is 40%. All assessments must be passed in order to pass the module.

Indicative reading

Peter Bennett, Morris Brown, and Pankaj Sharma (2015) Clinical Pharmacology. Livingstone.

See the library reading list for this module (Medway)

Learning outcomes

The intended subject specific learning outcomes.
On successfully completing the module students will be able to:
Describe evidence-based drug therapy and the significance of the randomised double-blind placebo controlled trial.
Understand what is meant by pharmacovigilance and pharmacoepidemiology.
Explain the possible sources of adverse drug interactions.
Understand the clinical pharmacology of the principal drugs used to treat infection and inflammation.
Demonstrate an understanding of how neuroactive drugs are used clinically in anaesthesia, pain management, and neurological disorders such as dementia, Parkinson's disease, epilepsy and multiple sclerosis.
Understand the clinical use of cholinergic, anti-muscarinic, and adrenergic drugs.
Critically evaluate how the various classes of diuretics are used clinically.
Describe the use and application of antitussives and respiratory stimulants.
Explain the clinical use of pro-coagulant and anti-coagulant drugs.
Appreciate the clinical use and application of the various classes of cytotoxic drugs in the treatment of cancer.
Understand the clinical use and application of drugs that effect gastrointestinal motility.
Understand the clinical application of anti-diabetes agents and anti-thyroid drugs.

The intended generic learning outcomes.
On successfully completing the module students will be able to:

Develop and demonstrate an ability to analyse, evaluate and correctly interpret data.
Present and communicate data effectively and confidently.
Obtain and use information from a variety of sources as part of self-directed learning.
Manage their time and use their organisation skills within the context of self-directed learning.
Develop and demonstrate an ability to work and communicate effectively with others.


  1. Credit level 6. Higher level module usually taken in Stage 3 of an undergraduate degree.
  2. ECTS credits are recognised throughout the EU and allow you to transfer credit easily from one university to another.
  3. The named convenor is the convenor for the current academic session.
Back to top

University of Kent makes every effort to ensure that module information is accurate for the relevant academic session and to provide educational services as described. However, courses, services and other matters may be subject to change. Please read our full disclaimer.